BMO Capital lowered the firm's price target on National Health Investors to $80 from $90 and keeps an Outperform rating on the shares as part of a broader research note on US Real Estate and Skilled Nursing Facilities. BMO notes that it's hard to have a firm view on the merits of the allegations of the recent short reports by Hunterbrook and Muddy Waters, but the firm is taking to heart that REITs have solid rent coverage levels, insulating them from potential downside, with strong supply/demand fundamentals, the analyst tells investors in a research note.
